A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

NHS England mental health survey shows record rise in psychiatric conditions, self-harm, and suicidal ideation.

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

You likely are accustomed to encountering a range of menus in daily life, but there is one that may be new to you: a dopamine ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...

Analysis: The government is expanding access to ADHD diagnosis, but experts warn medication alone won't fix NZ's systemic ...